HSE pays 47% more for 'brand name' drugs

A new survey has found that Ireland's Health Service is paying one-and-a-half times more than Britain for brand name medicines.

The study carried out for the Swedish pharmaceutical sector shows that Ireland pays more than any other Northern European country for drugs that are still under patent.

The survey found that the HSE pays 47% more than Britain's NHS for such "brand name" drugs.

Email Updates

Receive our lunchtime briefing straight to your inbox

More in this Section

No winner of the Lotto jackpot

Rescue teams focus on locating missing crew as weather looks set to improve

Gardai investigating claims Cork woman held against her will

Bus strike looms as Bus Eireann look to implement cost-cutting measures immediately


Today's Stories

PJs-wearing man assaulted neighbour with perfume

Ireland top of the table for drinking at home

Incinerator stalled over helicopter safety concerns

Row in Cabinet over flood relocation scheme

Lifestyle

Well known Irish faces write letters to their mums for Mother's Day

Thandie Newton gets in Line for top cop drama

Omid Djalili brings his unique comedy style to Ireland

Five Irish people share their favourite poems of all time

More From The Irish Examiner